Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Ophthalmol ; 7(1): 40-8, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9101194

RESUMO

PURPOSE: To assess the advantages and adverse effects of intraoperative low-dose Mitomycin C in filtering glaucoma surgery. METHODS: Sixty eyes of 48 patients undergoing surgery for uncontrolled glaucoma were randomized to two groups: one underwent standard trabeculectomy, the other had trabeculectomy with intraoperative application of 0.1 mg/ml mitomycin C. Follow-up was at least one year. RESULTS: The success rate (IOP < 18 mmHg) was 96.6% in the mitomycin C group and 73.3% in the control group. Mean IOP at one year of successful cases was 11.1 +/- 3.1 mmHg in the mitomycin C group and 16.4 +/- 6.1 mmHg in controls (p < 0.0001). Two patients in the mitomycin C group (6.6%) and six (20%) in the control group needed antiglaucomatous drugs to keep IOP below 18 mmHg. CONCLUSIONS: Mitomycin C is a useful adjunct to glaucoma surgery. Adverse effects at the dosage used are mainly due to hypotony and are preventable with two-layer suture. Low-dose mitomycin C may be useful in standard primary trabeculectomy.


Assuntos
Antibióticos Antineoplásicos/administração & dosagem , Glaucoma de Ângulo Aberto/tratamento farmacológico , Mitomicina/administração & dosagem , Trabeculectomia , Administração Tópica , Adulto , Idoso , Idoso de 80 Anos ou mais , Antibióticos Antineoplásicos/uso terapêutico , Quimioterapia Adjuvante , Doença Crônica , Feminino , Seguimentos , Glaucoma de Ângulo Aberto/fisiopatologia , Glaucoma de Ângulo Aberto/cirurgia , Humanos , Pressão Intraocular , Masculino , Pessoa de Meia-Idade , Mitomicina/efeitos adversos , Mitomicina/uso terapêutico , Soluções Oftálmicas , Estudos Prospectivos , Resultado do Tratamento , Acuidade Visual , Campos Visuais
2.
Mol Aspects Med ; 15 Suppl: s221-30, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-7752834

RESUMO

Phosphorus magnetic resonance spectroscopy (31P-MRS) has emerged as a noninvasive reliable tool for in vivo study of human tissue bioenergetics. It detects and quantifies some phosphorylated compounds present in millimolar concentration inside the cell, including ATP, phosphocreatine (PCr) and inorganic phosphate (Pi). By 31P-MRS we studied brain and skeletal muscle energy metabolism of three patients with retinitis pigmentosa before and after oral coenzyme Q10 (CoQ10) (100 mg/day). Before treatment we found a low PCr content in the brains of all patients, accompanied by a high [Pi] and high [ADP]. In two of three patients CoQ10 treatment resulted in a larger brain energy reserve mainly shown by an increased [PCr]. Abnormal muscle mitochondrial function was found only in one patient as shown by a reduced rate of PCr resynthesis after exercise. In this patient CoQ10 treatment resulted in an increased rate of PCr resynthesis. Our observations indicate that CoQ10 can improve mitochondrial functionality in the brain and skeletal muscle of patients with retinitis pigmentosa.


Assuntos
Metabolismo Energético/efeitos dos fármacos , Espectroscopia de Ressonância Magnética , Mitocôndrias Musculares/química , Retinose Pigmentar/tratamento farmacológico , Ubiquinona/análogos & derivados , Córtex Visual/química , Trifosfato de Adenosina/análise , Adolescente , Adulto , Coenzimas , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fosfatos/análise , Fosfocreatina/análise , Isótopos de Fósforo , Retinose Pigmentar/metabolismo , Ubiquinona/farmacologia , Ubiquinona/uso terapêutico
3.
J Chromatogr ; 541(1-2): 273-84, 1991 Mar 22.
Artigo em Inglês | MEDLINE | ID: mdl-2037650

RESUMO

Previously two fully automated methods based on column switching and high-performance liquid chromatography have been described, one for plasma and urinary catecholamines and the other for catecholamine urinary metabolites. Improvements in these methods, after 3 years of routine application, are now reported. The sample processing scheme was changed in order to eliminate memory effects and, in the procedure for plasma catecholamines, a pre-analytical deproteinization step was added which enhances the analytical column lifetime. The applied voltages for the electrochemical detector have been optimized, resulting in an automated method, suitable for the simultaneous determination of vanillylmandelic acid, 3,4-dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindoleacetic acid. The sensitivity of the methods allows the detection of 2-3 ng/l of plasma catecholamines and 0.01-0.06 mg/l of urinary metabolites. Also, it is possible to switch from one method to the other in only 30 min. The normal values obtained from 200 healthy people are reported, together with a list of 57 potential interfering substances tested.


Assuntos
Catecolaminas/metabolismo , Cromatografia Líquida de Alta Pressão/instrumentação , Catecolaminas/sangue , Catecolaminas/urina , Eletroquímica , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...